Sensus Healthcare is a medical device company focused on providing treatments for both oncological and non-oncological skin conditions. Co. uses a proprietary low-energy X-ray technology known as superficial radiation therapy (SRT) and has incorporated SRT into a portfolio of treatment devices: the SRT-100, which is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; SRT-100+, which provides the same features as the SRT-100, with the addition of remote diagnostics; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application. The SRTS stock yearly return is shown above.
The yearly return on the SRTS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SRTS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|